Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06821412 · ClinicalTrials.gov registry record · NA
Wireless Prosthetic Control Effectiveness Study
A NA study, sponsored by Liberating Technologies.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT06821412: Completed NA study, sponsored by Liberating Technologies.
NCT06821412 is a NA study that has completed, run by Liberating Technologies. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06821412, a NA study, has completed, sponsored by Liberating Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The goal of this proposed project is to evaluate the effectiveness of our novel wireless electrode system, which the investigators refer to as the Asterisk system, on transradial prosthesis users. There are numerous benefits to the upper limb prosthesis community being able to utilize wireless electrodes. These benefits include allowing for the use of a prosthetics liner to assist with fit and comfort, easier implementation of electromyography (EMG) controlled (also referred to as myoelectric control) prosthesis for individuals with osseointegration, and additional EMG electrode location options if the muscle activity captured within the prosthetic socket does not provide reliable prosthesis control. The investigators intend to use this data to develop the Asterisk wireless electrode system into a commercial product. The findings will also be shared with the research community to help drive the design of future devices.
Primary Outcome
The Orthotics and Prosthetics User's Survey (OPUS) is a self-report questionnaire consisting of five modules. The version of the OPUS which will be administered consists of 9 questions in 1 category (satisfaction with device). Questions are asked and scored on a scale from 0-4 (0=strongly disagree, 1=disagree, 2=neither agree nor disagree, 3=agree, and 4=strongly agree), with a higher value indicating a better outcome. There is an additional response for "Don't know / Not Applicable", which if c
Interventions
- DEVICE ASTERISK System
- DEVICE Wired Configuration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2024-06-13 |
| Est. Completion | 2025-06-12 |
| Phase | NA |
What the finished NCT06821412 record still lists
NCT06821412 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which ASTERISK System is the first listed.
NCT06821412 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06821412 about?
NCT06821412 is a clinical study titled "Wireless Prosthetic Control Effectiveness Study". The goal of this proposed project is to evaluate the effectiveness of our novel wireless electrode system, which the investigators refer to as the Asterisk system, on transradial prosthesis users. There are numerous benefits to the upper limb prosthesis community being able to utilize wireless elect...
What is the current status of trial NCT06821412?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2024-06-13. Estimated completion is 2025-06-12.
What interventions are being tested in trial NCT06821412?
The interventions under investigation include: ASTERISK System (DEVICE), Wired Configuration (DEVICE).
Who is sponsoring clinical trial NCT06821412?
This trial is sponsored by Liberating Technologies, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06821412's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI